APA (7th ed.) Citation

Mamidi, S., Cinci, M. L., Hasmann, M., Fehring, V., & Kirschfink, M. (2013). Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab. Molecular oncology, 7(3), . https://doi.org/10.1016/j.molonc.2013.02.011

Chicago Style (17th ed.) Citation

Mamidi, Srinivas, Marc L. Cinci, Max Hasmann, Volker Fehring, and Michael Kirschfink. "Lipoplex Mediated Silencing of Membrane Regulators (CD46, CD55 and CD59) Enhances Complement-dependent Anti-tumor Activity of Trastuzumab and Pertuzumab." Molecular Oncology 7, no. 3 (2013). https://doi.org/10.1016/j.molonc.2013.02.011.

MLA (9th ed.) Citation

Mamidi, Srinivas, et al. "Lipoplex Mediated Silencing of Membrane Regulators (CD46, CD55 and CD59) Enhances Complement-dependent Anti-tumor Activity of Trastuzumab and Pertuzumab." Molecular Oncology, vol. 7, no. 3, 2013, https://doi.org/10.1016/j.molonc.2013.02.011.